771 related articles for article (PubMed ID: 28557822)
21. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
22. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome.
Hartstra AV; Schüppel V; Imangaliyev S; Schrantee A; Prodan A; Collard D; Levin E; Dallinga-Thie G; Ackermans MT; Winkelmeijer M; Havik SR; Metwaly A; Lagkouvardos I; Nier A; Bergheim I; Heikenwalder M; Dunkel A; Nederveen AJ; Liebisch G; Mancano G; Claus SP; Benítez-Páez A; la Fleur SE; Bergman JJ; Gerdes V; Sanz Y; Booij J; Kemper E; Groen AK; Serlie MJ; Haller D; Nieuwdorp M
Mol Metab; 2020 Dec; 42():101076. PubMed ID: 32916306
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota, obesity and metabolic disorders.
Federico A; Dallio M; DI Sarno R; Giorgio V; Miele L
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):337-344. PubMed ID: 28927249
[TBL] [Abstract][Full Text] [Related]
24. The gut microbiome and metabolic syndrome.
Dabke K; Hendrick G; Devkota S
J Clin Invest; 2019 Oct; 129(10):4050-4057. PubMed ID: 31573550
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults.
Lippert K; Kedenko L; Antonielli L; Kedenko I; Gemeier C; Leitner M; Kautzky-Willer A; Paulweber B; Hackl E
Benef Microbes; 2017 Aug; 8(4):545-556. PubMed ID: 28701081
[TBL] [Abstract][Full Text] [Related]
26. Brain-gut-microbiota axis in depression: A historical overview and future directions.
Chang L; Wei Y; Hashimoto K
Brain Res Bull; 2022 May; 182():44-56. PubMed ID: 35151796
[TBL] [Abstract][Full Text] [Related]
27. The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.
Wijdeveld M; Nieuwdorp M; IJzerman R
Expert Opin Ther Targets; 2020 Jul; 24(7):639-653. PubMed ID: 32441559
[TBL] [Abstract][Full Text] [Related]
28. Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes.
Chen X; Devaraj S
Curr Diab Rep; 2018 Oct; 18(12):129. PubMed ID: 30338410
[TBL] [Abstract][Full Text] [Related]
29. Irritable bowel syndrome, the microbiota and the gut-brain axis.
Raskov H; Burcharth J; Pommergaard HC; Rosenberg J
Gut Microbes; 2016 Sep; 7(5):365-83. PubMed ID: 27472486
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota alterations and dietary modulation in childhood malnutrition - The role of short chain fatty acids.
Pekmez CT; Dragsted LO; Brahe LK
Clin Nutr; 2019 Apr; 38(2):615-630. PubMed ID: 29496274
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
[TBL] [Abstract][Full Text] [Related]
33. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
34. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
35. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome.
Lim MY; You HJ; Yoon HS; Kwon B; Lee JY; Lee S; Song YM; Lee K; Sung J; Ko G
Gut; 2017 Jun; 66(6):1031-1038. PubMed ID: 27053630
[TBL] [Abstract][Full Text] [Related]
36. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.
Westfall S; Lomis N; Kahouli I; Dia SY; Singh SP; Prakash S
Cell Mol Life Sci; 2017 Oct; 74(20):3769-3787. PubMed ID: 28643167
[TBL] [Abstract][Full Text] [Related]
37. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry.
Sandhu KV; Sherwin E; Schellekens H; Stanton C; Dinan TG; Cryan JF
Transl Res; 2017 Jan; 179():223-244. PubMed ID: 27832936
[TBL] [Abstract][Full Text] [Related]
38. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice.
Hong CP; Park A; Yang BG; Yun CH; Kwak MJ; Lee GW; Kim JH; Jang MS; Lee EJ; Jeun EJ; You G; Kim KS; Choi Y; Park JH; Hwang D; Im SH; Kim JF; Kim YK; Seoh JY; Surh CD; Kim YM; Jang MH
Gastroenterology; 2017 Jun; 152(8):1998-2010. PubMed ID: 28246016
[TBL] [Abstract][Full Text] [Related]
39. The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease.
Sundman MH; Chen NK; Subbian V; Chou YH
Brain Behav Immun; 2017 Nov; 66():31-44. PubMed ID: 28526435
[TBL] [Abstract][Full Text] [Related]
40. Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite.
van de Wouw M; Schellekens H; Dinan TG; Cryan JF
J Nutr; 2017 May; 147(5):727-745. PubMed ID: 28356427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
